| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0004 |